Feb 18, 2021
LEXINGTON, Ky. (February 18, 2021) – Dr. Rebecca Dutch, chair of UK’s Department of Molecular & Cellular Biochemistry, continues to help lead researchers and faculty from multiple disciplines across the University of Kentucky as part of the global effort to treat, understand and eradicate COVID-19.
Dutch last spoke with Behind the Blue in April of 2020, discussing the COVID-19 Unified Research Experts (CURE) Alliance team, a workgroup within UK’s College of Medicine, which works to bring together UK experts from across the campus to focus on advising COVID-19 patient care and clinical trials based on emerging research and potential treatment options.
On this episode of Behind the Blue, Dutch talks about the new vaccines being used to combat the coronavirus, the genetic variations of the virus that are appearing in different parts of the world, her outlook for when we may emerge from the pandemic, and more.
Read more about CURE here: http://uknow.uky.edu/research/university-kentucky-researchers-unite-fight-covid-19
"Behind the Blue" is available on iTunes, Google Play, Stitcher and Spotify. Become a subscriber to receive new episodes of “Behind the Blue” each week. UK’s latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university.
For questions or comments about this or any other episode of "Behind the Blue," email BehindTheBlue@uky.edu or tweet your question with #BehindTheBlue. Transcripts for this or other episodes of Behind the Blue can be downloaded from the show’s blog page.
To discover what’s wildly possible at the University of Kentucky, click here.